Skip to main content
Andrew Fesnak, MD, Pathology, Philadelphia, PA, Hospital of the University of Pennsylvania

AndrewDavidFesnakMD

Pathology Philadelphia, PA

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology

Clinical Pathology Resident Physician- PGY2

Dr. Fesnak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fesnak's full profile

Already have an account?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2011 - 2015
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2011
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Blood Banking/Transfusion Medicine

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2011 - 2024
  • American Board of Pathology Pathology - Clinical
  • American Board of Pathology Blood Banking/Transfusion Medicine

Publications & Presentations

PubMed

Abstracts/Posters

  • First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to El...
    Andrew Fesnak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma
    Andrew Fesnak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Drones Land in the Cell and Gene Therapy Space
    Drones Land in the Cell and Gene Therapy SpaceJuly 5th, 2019
  • Penn Medicine Launches COVID-19 Convalescent Plasma Study
    Penn Medicine Launches COVID-19 Convalescent Plasma StudyApril 22nd, 2020

Hospital Affiliations